See All Slides - tctmd.com

Slides

Presentation TCT 2014

A New Thin-Strut, Low-Dose, Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating: Safety and Efficacy Clinical Performance of the Inspiron? Stent in___

Presenter: Guy F Prado Jr

September 16, 2014

Presentation TCT 2014

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

Presenter: Hiroyoshi Yokoi

September 16, 2014

Presentation TCT 2014

Clinical Outcomes of Patients With High Risk Acute Coronary Syndrome Treated With a New Generation Drug-Eluting Stent, Ultimaster compared with Xience ? Results from CENTURY II___

Presenter: Kazushige Kadota

September 16, 2014

Presentation TCT 2014

Detection of Paclitaxel Contamination Resulting from the Simulated Clinical Use of Drug Coated Balloon Catheters

Presenter: Charisse Ward

September 16, 2014

Presentation TCT 2014

Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis

Presenter: Luis Nombela-Franco

September 16, 2014

Presentation TCT 2014

Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: A Report from NCDR

Presenter: Emmanouil Brilakis

September 16, 2014

Presentation TCT 2014

First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

Presenter: Horst Sievert

September 16, 2014

Presentation TCT 2014

Improvement Of Left Ventricular Function Assessment By Global Longitudinal Strain After Successful Percutaneous Coronary Intervention For Chronic Total Occlusions

Presenter: Misato Chimura

September 16, 2014

Presentation TCT 2014

Bipolar Radiofrequency Renal Denervation With The Vessix Balloon Catheter System: Preclinical Safety Evaluation Through 180 Days

Presenter: Gregory Wilson

September 16, 2014

Presentation TCT 2014

Tongxinluo reduces infarct size by promoting endothelial adhesion junction integrity in reperfused diabetic hearts via PPAR-? pathway

Presenter: Kang Qi

September 16, 2014

Advertisement

Slides

A New Thin-Strut, Low-Dose, Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating: Safety and Efficacy Clinical Performance of the Inspiron? Stent in___

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

Clinical Outcomes of Patients With High Risk Acute Coronary Syndrome Treated With a New Generation Drug-Eluting Stent, Ultimaster compared with Xience ? Results from CENTURY II___

Detection of Paclitaxel Contamination Resulting from the Simulated Clinical Use of Drug Coated Balloon Catheters

Clinical Impact and Evolution Of Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: A Meta-Analysis

Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: A Report from NCDR

First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

Improvement Of Left Ventricular Function Assessment By Global Longitudinal Strain After Successful Percutaneous Coronary Intervention For Chronic Total Occlusions

Bipolar Radiofrequency Renal Denervation With The Vessix Balloon Catheter System: Preclinical Safety Evaluation Through 180 Days

Tongxinluo reduces infarct size by promoting endothelial adhesion junction integrity in reperfused diabetic hearts via PPAR-? pathway

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content